We report here the crystallographic and biophysical analysis of a soluble, catalytically active fragment of the Escherichia coli type I signal peptidase (SPase ⌬2-75) in complex with arylomycin A 2 . The 2.5-Å resolution structure revealed that the inhibitor is positioned with its COOH-terminal carboxylate oxygen (O45) within hydrogen bonding distance of all the functional groups in the catalytic center of the enzyme (Ser 90 O-␥, Lys 145 N-, and Ser 88 O-␥) and that it makes ␤-sheet type interactions with the ␤-strands that line each side of the binding site. Ligand binding studies, calorimetry, fluorescence spectroscopy, and stopped-flow kinetics were also used to analyze the binding mode of this unique non-covalently bound inhibitor. The crystal structure was solved in the space group P4 3 2 1 2. A detailed comparison is made to the previously published acyl-enzyme inhibitor complex structure (space group: P2 1 2 1 2) and the apo-enzyme structure (space group: P4 1 2 1 2). Together this work provides insights into the binding of pre-protein substrates to signal peptidase and will prove helpful in the development of novel antibiotics.
Type I signal (leader) peptidase (SPase, 1 EC 3.4.21.89 ) is the membrane-bound serine endopeptidase that catalyzes the cleavage of the amino-terminal signal (or leader) peptide from secretory proteins and some membrane proteins (for recent reviews, see Refs. 1-3). Evolutionarily, SPase belongs to the protease clan SF and the protease family S26 (4) . The Escherichia coli SPase has served as the model Gram-negative SPase and is the most thoroughly characterized SPase to date. It has been cloned (5), sequenced (6) , overexpressed (7), purified (6, 8, 9) , and kinetically (10) , and structurally (11, 12) characterized. E. coli SPase (323 amino acids, 35,988 Da, pI 6.9) contains two amino-terminal transmembrane segments (residues 4 -28 and 58 -76), a small cytoplasmic region (residues 29 -58) , and a carboxyl-terminal periplasmic catalytic region (residues 77-323). A catalytically active fragment of SPase (SPase ⌬2-75) corresponding to the periplasmic region (lacking the two transmembrane segments and the cytoplasmic domain) has been cloned, purified, characterized (13, 14) , and crystallized (15) . Interestingly, the ⌬2-75 construct required detergent or lipid for optimal activity (14) and crystallization (15) .
The crystal structure of ⌬2-75 has been solved in complex with a ␤-lactam-type inhibitor as well in the apo-form (11, 12) . The structures of E. coli SPase ⌬2-75 revealed that the periplasmic region of bacterial signal peptidase has a unique, mostly ␤-structure protein fold made of several coiled ␤-sheets and contains an Src homology 3-like barrel. The periplasmic region of SPase is made up of two domains. Domain I contains the catalytic residues and all of the conserved regions of sequence. It also contains an unusually large exposed hydrophobic surface that is consistent with a membrane association surface and possibly the detergent/lipid requirement of the ⌬2-75 deletion construct. The second ␤-sheet domain, domain II, is an insertion within domain I and appears to be mostly present in Gram-negative signal peptidases (16) .
Site-directed mutagenesis (10, 17) , chemical modification (10, 18) , and crystallographic (11, 12) studies are consistent with SPase utilizing a Ser-Lys dyad mechanism whereby Ser 90 serves as the nucleophile and Lys 145 serves as the general base. Kinetic analysis of site-directed mutants designed using the crystal structure (11) has revealed that E. coli SPase contains an unusual oxyanion hole that uses hydrogen bonds from a serine hydroxyl hydrogen (Ser 88 O-␥H) and a main chain amide hydrogen (Ser 90 NH) to stabilize the transition state oxyanion at the scissile bond (19) . The crystal structures with and without covalently bound inhibitor have helped to explain the Ala-X-Ala substrate specificity by revealing two shallow hydrophobic pockets (S1 and S3) adjacent to the catalytic residues and leading to the proposed membrane association surface (11, 12) . The structures also reveal that SPase is an unusual serine protease in that it attacks the scissile amide bond of the substrate from the si-face rather than the re-face, as seen in most serine proteases (20, 21) .
It has been observed in many laboratories that bacterial type I SPases are not inhibited by standard protease inhibitors (13, (22) (23) (24) . The first effective synthetic signal peptidase inhibitors to be discovered were described by Kuo and collegues in 1994 (25) . They showed that ␤-lactam analogs inhibited E. coli SPase. The most effective ␤-lactam (penem) compounds are the 5 S stereoisomers (26) . A crystal structure of E. coli SPase ⌬2-75 has been solved with the compound allyl (5S,6S)-6-((R)-acetoxyethyl)-penem-3-carboxylate covalently bound to the nucleophilic Ser 90 O-␥ (11). It has also been previously observed that E. coli SPase can be competitively inhibited by signal peptides or by pre-proteins with proline at the P1Ј (ϩ1) position (27, 28) .
Arylomycin A 2 is a member of a recently described class of antibiotics (29) that have been shown to be inhibitors of SPase. Arylomycins are lipohexapeptides (D-MeSer-D-Ala-Gly-L-MeHpg-L-Ala-L-Tyr) with a 12-carbon atom branched fatty acid (isoC12) attached via an amide bond to the amino terminus (Fig. 1) . The amino acid residue MeHpg is N-methyl-4-hydroxyphenyglycine. Interestingly, the MeHpg is cross-linked via the ortho-carbon atom of its phenol ring to the ortho-carbon atom in the phenol ring of the Tyr residue forming a (3,3)-biaryl bridge. This cross-link creates a 3-residue ring-type structure within the peptide. Two of the backbone amide nitrogen atoms (MeSerN1 and MeHpgN16) are methylated. The first two residues have D-stereochemistry. The crystallographic and biophysical analysis of the mode of binding of this inhibitor in the substrate binding cleft of E. coli signal peptidase reveals the mechanism of inhibition for this non-covalently bound peptidebased inhibitor and also may give us important insights into the binding interactions involved in pre-protein binding and cleavage by type I signal peptidase.
EXPERIMENTAL PROCEDURES
Materials-The SPase ⌬2-75 protein (relative molecular mass (M r ) 27,952 by electrospray ionization mass spectrometry analysis (13) (249 amino acid residues, measured isoelectric point of 5.6 (15)) was expressed and purified as described previously (15) . The ⌬2-75 protein (10 mg/ml) was suspended in 20 mM Tris-HCl, pH 7.4, and 0.5% Triton X-100. The inhibitor arylomycin A 2 was isolated from Streptomyces as described by Schimana et al. (29) .
Co-crystallization and Data Collection-Arylomycin A 2 , dissolved in Me 2 SO and water, was added to the SPase ⌬2-75 protein at a 1:1 mole ratio and allowed to sit on ice for Ͼ30 min and then stored at Ϫ20°C. The crystals were grown by sitting drop vapor diffusion with a reservoir consisting of 0.5% Triton X-100, 15% PEG 4000, 20% propanol-1, and 0.1 M sodium citrate, pH 6.0. The drop consisted of 1 l of the proteininhibitor mixture and 1 l of the reservoir solution. The crystals belong to the tetragonal space group P4 3 2 1 2 with unit cell dimensions of a ϭ 69.6 Å, b ϭ 69.6 Å, c ϭ 258.5 Å. Given the unit cell dimensions and the molecular mass, the specific volume (V m (30) ) is 2.8 Å 3 /Da for two molecules in the asymmetric unit. Before data collection, the crystal was soaked in a cryosolution that consisted of the same conditions as the crystallization mother liquor with the addition of 20% glycerol. The x-ray diffraction intensities were measured at 100 K on beamline X8C at the Brookhaven National Laboratory, National Synchrotron Light Source (NSLS). The data were processed using DENZO and SCALE-PACK (31) . See Table I for data collection statistics.
Phasing, Model Building, and Refinement-A molecular replacement solution was found using the program AmoRe (32) . Molecule A from the previously published inhibitor acyl-enzyme crystal structure of E. coli SPase ⌬2-75 was used as a search model (Ref. 11; Protein Data Bank code 1b12). Model building and analysis was performed with the program XFIT within the suite XTALVIEW (33) . Refinement of the structure was carried out using the program CNS (34) . The topology and parameter files for the lipohexapeptide inhibitor were generated using the programs XPLO2D (35) and PRODRG (36) . The stereochemistry of the molecular models was analyzed with the programs PROCHECK (37) .
Structural Analysis-The secondary structural analysis was performed with the program PROMOTIF (38) . The utilities Lsq_explicit, Lsq_improve, and Lsq_molecule within the program O (39) were used to superimpose the ⌬2-75 molecules for comparing the different molecules in the asymmetric unit or for comparing molecules from different structures. The program CONTACT within the program suite CCP4 (32) was used to measure the hydrogen bond and van der Waals contacts between the inhibitor and the enzyme. The program CAST (40) was used to measure the S1 and S3 binding sites. The program SURFACE RACER 1.2 (41) was used to measure the solvent accessible surface. A probe radius of 1.4 Å was used in the calculations.
Figure Preparation- Fig. 1 was prepared using the program ISIS Draw version 2.1.4 (MDL Information Systems, Inc.). Fig. 2 was prepared using the programs XFIT (33) and Raster3D (42) . Figs. 3 and 4 were prepared using the programs Molscript (43) and Raster3D (42) .
Accession Numbers-Atomic coordinates for the SPase ⌬2-75 peptide-based inhibitor (arylomycin A 2 ) complex structure have been deposited with the RCSB Protein Data Bank (44) under accession code 1T7D. Atomic coordinates for the SPase ⌬2-75 ␤-lactam-type inhibitor acyl-enzyme complex structure (11) are under accession code 1B12 and the SPase ⌬2-75 apo-enzyme structure (12) is under accession code 1KN9.
Fluorescence Spectroscopy of Ligand Binding-Steady-state fluorescence measurements were made using a PerkinElmer LS-50 spectrofluorimeter. Spectra were recorded between 250 and 300 nm for excitation and between 310 and 450 nm for emission. The protein concentration was between 1 and 10 mM and ligand was in excess. Both enzyme and ligand were in 20 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 1% Elugent TM detergent and all experiments were carried out at 25°C.
Stopped-flow Experiments under Conditions of Excess Substrate-
The kinetics of arylomycin A 2 binding to SPase were investigated by stopped-flow fluorescence and stopped-flow fluorescence anisotropy on a model SF-61 DX2 stopped-flow spectrometer from Hi-Tech. The excitation wavelengths in each case were set using a monochromator and the fluorescence emission was measured using a filter with a cut-off 2 M. G. P. Page, manuscript in preparation. below 360 nm. For stopped-flow fluorescence measurements the excitation wavelength was set at 280 nm to excite the arylomycin A 2 molecule through the tryptophans of the SPase enzyme, whereas for anisotropy measurements the excitation wavelength was set at 310 nm to excite the ligand directly. In all cases the stopped-flow fluorescence data used for analysis were the average of 5 kinetic runs obtained under the exact same conditions and concentrations.
The rate of binding was measured under conditions of excess substrate, with the SPase concentration kept at 6.25 M and the ligand concentration varied in the range 7.5-50 M and under conditions of excess enzyme with the enzyme concentration again at 6.25 M and the ligand concentration varied in the concentration range 0.05-5 M. Both enzyme and ligand were in 20 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 1% Elugent TM detergent and all experiments were carried out at 25°C. Stopped-flow data were fitted to a double exponential equation of the form,
where ⌬F is the total change in fluorescence, ⌬F 1 and ⌬F 2 are the fluorescence changes associated with rate constants k 1 and k 2 , k 1 and k 2 are first-order rate constants, and c is the offset. The observed rate of binding under conditions of excess substrate was then plotted against the ligand concentration and fitted to Equation 2,
where k obs (s Ϫ1 ) is the observed first-order rate of binding, k off (s Ϫ1 ) is the first-order rate constant for dissociation, k on (M Ϫ1 s Ϫ1 ) is the secondorder rate constant for association (28) , and M is the concentration of free ligand.
Differential Scanning Calorimetry-The thermal stability of signal peptidase under various conditions was investigated by differential scanning calorimetry using a Microcal VP-DSC (Microcal Inc.) microcalorimeter. Solutions of 12.5 M SPase in 20 mM Hepes-NaOH, 1% Elugent TM detergent, with and without 100 M arylomycin A 2 were used as samples. All solutions were thoroughly degassed before use and the reference cell in each case was filled with an aliquot of buffer against which the protein solution had previously been dialyzed overnight. All samples were scanned from 30 to 70°C, at a rate of 1°C/min and data were baseline corrected, smoothed using a Savitsky-Golay 9 point smoothing algorithm, and analyzed using the Origin Scientific plotting software.
Isothermal Titration Calorimetry-Determination of the binding constant and full thermodynamic description of the interaction of SPase with arylomycin A 2 was achieved by isothermal titration calorimetry using a Microcal. Arylomycin A 2 was dissolved in 20 mM Tris-HCl, 5 mM MgCl 2 , 1% Elugent TM detergent, pH 7.4, to a concentration of 450 M and 33 separate injections were made into 1.4 ml of 15 M SPase in the sample cell during one calorimetric run. For each run the resulting isotherm allows the number of binding sites for the ligand on each molecule, the binding association constant, and the change in reaction enthalpy upon binding to be calculated.
RESULTS

A New Crystal Form of the Catalytic Domain of E. coli Type I Signal Peptidase
Initial attempts to soak the arylomycin A 2 into pre-formed crystals of ⌬2-75 were unsuccessful. Therefore new conditions were developed to co-crystallize the SPase ⌬2-75 with the inhibitor. The crystals described here belong to the tetragonal crystallographic space group P4 3 2 1 2 and gave ordered diffraction out to 2.5 Å. This constitutes the third space group in which ⌬2-75 has been crystallized and the structure solved. The acyl-enzyme inhibitor complex crystals had the orthorhombic space group P2 1 2 1 2 (11) and the apo-enzyme crystals had the tetragonal space group P4 1 2 1 2 (12). The arylomycin A 2 -SPase ⌬2-75 complex crystals described here form in polyethylene glycol 4000 and propanol-1, which is significantly different from the previously described crystallization conditions that used ammonium dihydrogen phosphate as the precipitant (15) (see "Experimental Procedures" for details). As with the previously described conditions, the detergent Triton X-100 was essential for crystallization. Also similar to the previous conditions, the buffer sodium citrate was used but in these new crystallization conditions the pH of the reservoir solution was pH 6.0 rather than 4.85.
Crystallographic Structure Solution of Signal Peptidase in Complex with Arylomycin A 2
A molecular replacement solution was found using the program AMORE (32) . Molecule A from the previously solved 1.9-Å inhibitor acyl-enzyme crystal structure (Protein Data Bank code 1B12 (11)) was used as the search model. The program EPMR was also successful in obtaining the same solution (45) . The initial F o Ϫ F c difference map revealed a large circular density with a tail consistent with the general shape of the inhibitor. A model of the inhibitor was built, along with the topology and parameter files needed for refinement, based on the structural and stereochemical analysis of arylomycin A 2 by Höltzel et al. (46) . Cycles of refinement and manual rebuilding of the protein model and inhibitor model using programs CNS and XFIT, respectively, were able to produce a model with a good fit to the experimental electron density (r ϭ 23.1, R free ϭ 28.5).
Analysis of Arylomycin A 2 in the Signal Peptidase Substrate Binding Site
An average of 481 Å 2 of solvent accessible surface area on E. coli SPase is buried by arylomycin A 2 bound in the active site. The inhibitor is bound with its COOH-terminal biaryl-bridged end pointing into the active site. It binds in a parallel ␤-sheet fashion making interactions with both of the ␤-strands that line the binding site of SPase (142-145 and 83-90). The center of the biaryl-bridged ring system of the inhibitor is positioned approximately between SPase residues Pro 87 and Leu 141 . All of the potential main chain hydrogen bond donors and acceptors in the inhibitors 3-residue biaryl-bridged ring system (MeHpg-L-Ala-L-Tyr) are positioned to make hydrogen bonds with SPase atoms, either directly or via water molecules. In contrast, only 2 of the 6 potential main chain hydrogen bond donors or acceptor (N7 and O15) in the NH 2 -terminal 3-residue tail of the inhibitor (D-MeSer-D-Ala-Gly) appear to make hydrogen bonds with SPase. Hydrogen bonding and van der Waals contacts between the lipohexapeptide inhibitor and SPase are depicted in Fig. 3 and in Table II . Interestingly, the carboxylate oxygen atom O45 of arylomycin A 2 is positioned into the SPase active site such that O45 makes hydrogen bonding interaction with each of the enzymes catalytic residues: the nucleophile Ser 90 O-␥, the general base Lys 145 N-, and the oxyanion hole Ser 88 O-␥. The C30 methyl group from the penultimate Ala side chain within the inhibitor points approximately into the S3 binding pocket (Table II) . The C9 methyl side chain of the D-Ala residue points into a shallow pocket formed from the SPase residues Pro 83 , Phe 84 , Gln 85 , Phe 100 , and Trp 300 . Although there is no electron density seen for the fatty acid group on the inhibitor (Fig. 2) , there is electron density for the methylated D-serine at the peptide inhibitors NH 2 terminus where the fatty acid is attached. This localizes the fatty acid near the proposed SPase membrane association surface (11) .
Comparison with the Acyl-enzyme and Apo-enzyme Structures of Signal Peptidase
As with the previously solved structures of ⌬2-75 SPase the nucleophilic Ser 90 O-␥ and the general base Lys 145 N-are within hydrogen bonding distance (3.1 Å, an average of the 2 molecules in the asymmetric unit).
Superposition of the acyl-enzyme (Protein Data Bank code 1B12) and the apo-enzyme (1KN9) structure onto the noncovalently bound inhibitor complex structure reveals that the 1 angle for Ser 88 is 74°(an average of the 2 molecules in the asymmetric unit), which is in agreement with the apo-enzyme structure and is consistent with this residue contributing a stabilizing hydrogen bond to the oxyanion carbonyl during the transition state (Fig. 4) . In the acyl-enzyme structure, the Ser The binding pocket of this arylomycin A 2 -signal peptidase complex appears to be a closer match to that of the acyl-enzyme complex structure than that of the apo-enzyme structure. For example, the phenyl ring side chain of Phe 84 as well as the main chain near Pro 87 are in a similar position to that seen in the penem-bound structure (Fig. 4) . Molecular surface analysis of the binding pocket region (S1/S3) confirms quantitatively that the volume of the pocket (246 Å 3 ) is closer to that of the acyl-enzyme (224 Å 3 ) than that of the apo-enzyme (129 Å 3 ) (40). Similar to both the apo-enzyme and acyl-enzyme structures, there is a buried water near Ser 90 (WAT290 in molecule A and WAT270 in molecule B). Molecule A in the arylomycin A 2 -SPase complex structure has a water (WAT289) in a similar position to that of WAT3 in the apoenzyme structure, except it is displaced by ϳ2 Å such that it can still coordinate with the ⑀-amino group of Lys 145 , which, as discussed above, has a significantly different 4 angle from the previously solved structures because of interactions with the inhibitor. The water designated as WAT3 in the apo-enzyme structural analysis was judged to be the most likely candidate to act as the deacylating water based on its position relative to the general base lysine a NS signifies that the water was not seen in the specified molecule of the asymmetric unit. b Inhibitor atom to water distance / water to protein atom distance.
FIG. 4.
Superposition of the active site residues in the apo-enzyme, acyl-enzyme, and non-covalently bound inhibitor structures of signal peptidase. A, the apo-enzyme active site residues are shown in green and the arylomycin A 2 bound signal peptidase active site residues are shown in red. B, the acyl-enzyme active site residues are shown in blue and the arylomycin A 2 bound signal peptidase active site residues are shown in red.
and its angle of nucleophilic attack on the scissile carbonyl (Bü rgi angle (48)). Arylomycin A 2 has displaced an ordered water (WAT 2 in the apoenzyme bound structure, average B factor ϭ 37.78) that was hydrogen bonded to Ile 144 N (average distance ϭ 3.2 Å). This interaction has been replaced by a strong hydrogen bond (average distance ϭ 2.6 Å) to O44 of arylomycin A 2 . By comparing the apo-enzyme and the arylomycin A 2 -bound structures we can see that the only interactions that are broken to form the final inhibitor-enzyme complex are the above mentioned displacement of the ordered water that interacted with Ile 144 N and the above mentioned broken intra-molecular interactions between Ser 278 O-␥ and Lys 145 N-.
Spectroscopic Analysis to Probe the Binding Mechanism of Arylomycin A 2 to Signal Peptidase
Steady-state Fluorescence Spectroscopy-Binding of arylomycin A 2 in the active site of SPase causes a change in the quantum yield of fluorescence emission at 417 nm upon excitation at 280 nm. This is caused most likely by the transfer of energy from tryptophan residue(s) in or around the active site of the SPase enzyme to the arylomycin A 2 molecule. The x-ray structure of the SPase-arylomycin A 2 complex shows that the ring of the cross-linked Tyr-Hpg moiety, when bound, lies flat against a large hydrophobic surface on one side of the SPase binding site and this too could have a contributing effect to an increase in fluorescence by reducing the quenching of the arylomycin A 2 molecule. The change in fluorescence associated with the binding of arylomycin A 2 to SPase as a function of the log of ligand concentration describes a sigmoidal binding curve, from which a value of 0.94 Ϯ 0.04 ϫ 10 Ϫ6 M for the binding dissociation constant (K d ) was calculated (Fig. 5) . This was close to the value of 0.61 Ϯ 0.03 ϫ 10 Ϫ6 M for the binding dissociation constant calculated from the reciprocal of the binding association constant determined by isothermal titration calorimetry (see below). The similarity of these two values and the fact that the fluorescence change reaches saturation at high inhibitor concentrations, as well as the goodness of fit of the isothermal titration calorimetry data to a curve describing a single binding site, demonstrates that the binding of arylomycin A 2 to SPase was specific to a single binding site and that fluorescence spectroscopy can be used to directly observe binding.
Stopped-flow Fluorescence Spectroscopy-The mode of binding of arylomycin A 2 was investigated by stopped-flow fluorescence spectroscopy. The data obtained were fitted to Equation 1 and the results are shown in Tables III and IV. The fit of all the data was demonstrated by F-test to be statistically much better to a double exponential curve than to a single exponential and this was the case for both fluorescence and anisotropy data (Fig. 6) . Also similar trends in the rate constants were observed in both the fluorescence and anisotropy data. Because, both the fluorescence measurements and the anisotropy measurements reveal the occurrence of two exponential processes the observed rate constants can be assumed to be associated with the binding of arylomycin A 2 to SPase and the nature of the two processes involved is hypothesized as the initial contact between the ligand and the enzyme followed by a slow rearrangement. This can be described by a reaction scheme of the type,
where the enzyme and substrate first combine to form an initial collisional complex (ES), followed by a slow isomerism to the final bound state (ES*).
When the concentration of ligand was in excess of SPase the amplitude of the faster of these rate constants becomes dominant, such that the amplitude of the slower rate constant is insignificant in comparison to the error in the fit of the curve. This causes a large underestimation of the slower rate constant upon fitting data obtained at high concentrations of substrate to Equation 1. However, it is clearly observable from the data in Tables III and IV that 
when the concentration of substrate moves from [S]Ͻ[E] to [S]Ͼ[E]
, the rate of the slower rate constant begins to increase until such a point as the fit becomes dominated by the faster rate constant.
The observed binding data obtained by stopped-flow fluorescence spectroscopy determined in the presence of excess substrate was fitted to Equation 1 and the faster rate constant with the greater amplitude was plotted as a linear plot according to Equation 2 (Fig. 7) . From this linear plot a value of 0.45 Ϯ 0.02 ϫ 10 6 M Ϫ1 s Ϫ1 was derived for the association rate constant (k on ) and a value of 0.48 Ϯ 0.46 s Ϫ1 for the dissociation rate constant (k off ). The value for the association rate constant is several orders of magnitude lower than the diffusion-controlled limit for binding. We can see from a comparison between the apo-enzyme structure and the arylomycin A 2 -bound structure that the associate rate is consistent with the many contacts that are formed between arylomycin A 2 and the SPase active site (Table II and Fig. 3 ) and the two hydrogen-bonding interactions that are broken to form the complex (described above). However, because it was impossible to derive data for the slower rate constant for values of substrate of 25 M and above, the values of the association and dissociation rate constants for the slower binding process could not be calculated.
When the concentration of the enzyme is in excess of ligand, both the faster and slower rate constants are independent of ligand concentration (Table III) . This relationship is predicted by the rate equation,
where the observed rate (k obs ) is pseudo first-order because the concentration of the enzyme is effectively unchanged during the reaction.
Binding Parameters Derived by Calorimetry
Differential Scanning Calorimetry-The stabilizing effect of contacts formed upon binding was investigated by measuring the melting transition (T m ) of SPase using differential scanning calorimetry. The melting transition of SPase with and without the addition of ligand was irreversible, indicating that the system cannot be treated as being purely under thermodynamic control. However, the melting curve could still be described by a simple two-state model indicating that the enzyme unfolded as a single domain essentially free from impurities or aggregated protein prior to the increase in temperature. There was a clear increase in the T m from 46.7 to 48.5°C for SPase upon binding arylomycin A 2 (Fig. 8 ). This increase in T m of 1.8°C was significant in comparison to the error associated with the technique of Ϯ0.3°C and was most likely caused by the formation of stabilizing interactions between ligand and the SPase enzyme upon binding (Table II and Fig. 3) .
Isothermal Titration Calorimetry-The binding isotherm generated by isothermal titration calorimetry was accurately fitted by a model for binding to one single binding site and gave a stoichiometry of binding of 0.95 mol of arylomycin A 2 /mol of SPase, a ⌬H cal of Ϫ7520 cal mol Ϫ1 and a K eq (association constant) of 1.65 Ϯ 0.1 ϫ 10 6 M Ϫ1 (Fig. 9) . Because this value for K eq was obtained using the same buffer conditions and at the same temperature as the stopped-flow fluorescence measurements, a value for the dissociation rate constant of 0.27 s Ϫ1 can be derived from the association rate constant calculated from the stopped-flow fluorescence measurements and the binding association constant obtained by isothermal titration calorimetry. This value is close to the k off value calculated directly by stopped-flow fluorescence of 0.48 s Ϫ1 and gives much greater confidence in this value in view of the very high standard error on the measurement. 
DISCUSSION
Here we have analyzed the structure and binding mode of the peptide-based signal peptidase inhibitor/antibiotic arylomycin A 2 . This colorless natural product isolated from Streptomyces extracts is classified as a secondary metabolite formed by non-ribosomal peptide synthesis (49, 50) . Arylomycin A 2 is one of a number of similar compounds differing in the type of fatty acid attached to the NH 2 terminus. There are actually two series of arylomycin compounds isolated and characterized (29, 46) . The arylomycin B series differs from the arylomycin A series in that the B series is yellow in color resulting from the substitution of the tyrosine residue by a 3-nitrotyrosine residue. These arylomycin compounds have demonstrated antibiotic activity (29) . Exchange peaks in the ROESY and NOESY spectra show that there is a cis-trans isomerization of the fatty acid-MeSer amide bond with the predominate geometry being trans (46) . This isomerization may have attributed to the lack of electron density for the fatty acid (Fig. 2) .
Although arylomycin A 2 is a novel biaryl-bridged lipohexapeptide, some of the structural aspects of this compound have been seen before. The Hpg residue (4-hydroxyphenyglycine) has been seen before in peptide-based antibiotics. The peptide antibiotic ramoplanin contains a Hpg residue and its structure has been solved by NMR (51) (Protein Data Bank code 1DSR). The biosynthetic pathway for 4-hydroxyphenyglycine has recently been determined (50) . As mentioned above the Hpg residue in arylomycin A 2 is cross-linked via its phenol ring ortho-carbon to the phenol ring ortho-carbon of the Tyr residue. Dityrosine cross-links are occasionally seen in proteins and can be formed photochemically or enzymatically (52) . The glycopeptide antibiotic vancomycin has a 3-residue ring system similar to arylomycin A 2 including the Hpg-Tyr cross-link. The crystal structure of vancomycin alone has been solved at atomic resolution (Protein Data Bank codes 1SHO (53) and 1AA5 (54)). Its structure has also been solved in complex with the cell wall precursor analog, di-acetyl-Lys-D-Ala-D-Ala (Protein Data Bank code 1FVM).
There is a large amount of literature supporting the idea that cyclization of peptides (macrocyclization) can cause a significant reduction in the conformational freedom that often results in increased receptor binding affinity (55) . Although it is possible that the biaryl-bridge in arylomycin A 2 could increase the rigidity and limit the conformational freedom of arylomycin A 2 such that fewer non-productive conformations would have to be sampled during the binding event with signal peptidase, this has proven to be difficult to test with the comparable linear peptide. Unfortunately, linear peptides based around arylomycin A 2 or substrate consensus sequences do not bind sufficiently tightly to measure the thermodynamic parameters. The entropy change (⌬S) from our isothermal titration calorimetry analysis of arylomycin A 2 binding to SPase is 11 J/mol, therefore the major thermodynamic factor is the reaction enthalpy presumably driven by hydrogen bonding interactions between the inhibitor and the signal peptidase binding site.
It is possible that the NH 2 -terminal fatty acid chain of arylomycin A 2 contributes to the effectiveness of the inhibitor by presenting the correct orientation of the inhibitor to the SPase binding site within the lipid bilayer in vivo or in the detergent micelle in in vitro assays. Peptide substrates designed for signal peptidase with NH 2 -terminal fatty acid tails show significantly more activity than that of similar peptides without fatty acids (56) . Although we do not see electron density for the fatty acid in this structure we do see density for the NH 2 terminus of the lipopeptide inhibitor where the fatty acid is attached (Fig.  2) . The NH 2 terminus of arylomycin A 2 is located adjacent to Trp 300 , which is part of the proposed SPase membrane association surface (Fig. 3) . Interestingly, Trp 300 has been shown by chemical modification and mutagenesis to be an important residue for SPase activity (57) .
Both the crystallographic analysis and the spectroscopic data are consistent with arylomycin A 2 binding specifically to a single binding site on SPase. The fluorescence data is most consistent with a two-step binding mechanism. This mecha- nism involves a rapid binding mode followed by a slow isomerism to the final bound state and these two separate binding events were readily identified by stopped-flow fluorescence because the isomerism step has a much lower rate than the formation of the initial collisional complex. A comparison of the active site regions of the apo-enzyme, acyl-enzyme, and the noncovalently bound complex with arylomycin A 2 (Fig. 4) shows that the proposed slow isomerization step of the twostate process of binding is unlikely to be the result of the need for large structural adjustments in SPase. The observed net effect on the SPase active site region upon binding of ligands is a change in the volume of the specificity subsites that is a result of a rotation in the side chain position of Phe 84 and some main chain movement near Pro 87 . Future NMR analysis of the structure and dynamics of arylomycin A 2 in solution may help provide insights into whether the slow isomerization step may be because of structural adjustments needed in the arylomycin A 2 molecule before the correct docking mode is established in the active site of SPase.
The relatively low value for the binding association rate constant of 0.45 Ϯ 0.02 ϫ 10 6 M Ϫ1 s Ϫ1 , in comparison to the diffusion controlled limit, demonstrates the breaking and formation of interactions during binding is in agreement with the stabilization of the melting temperature measured by DSC. These biophysical results are consistent with the crystallographic analysis that revealed that the final arylomycin A 2 bound form of the enzyme requires the formation of many new intermolecular interactions between the enzyme and arylomycin A 2 (Table II and Fig. 3) . Interestingly, the formation of the final complex requires the breaking of only one intra-molecular hydrogen bond (Ser 278 O-␥ to Lys 145 N-) and the displacing of one water that was observed in the binding site in the apo structure (WAT2 (12)). Further experiments will need to be performed to analyze the temperature dependence and activation energies of the individual binding steps to make a connection between the slow binding association rate and the thermodynamic stabilization of the final inhibitor-enzyme complex.
The observed interactions between this non-covalently bound hexapeptide inhibitor and SPase agree very well with the previously proposed model of a signal peptide bound in the active site of E. coli signal peptidase (12) , which was based on the crystal structure of the LexA cleavage site (58) . Both the model and the inhibitor complex show hydrogen-bonding interactions with both the main chain carbonyl and amide of Gln 85 . Because the COOH-terminal carboxyl group of the inhibitor sits approximately where the P1 residue of the pre-protein substrate would reside, the interactions with the strand containing the general base lysine are not quite the same. The L-Ala methyl side chain (C30) of arylomycin A 2 sits in the shallow hydrophic pocket, which was proposed previously from modeling studies to be the S3 binding pocket. The D-Ala methyl side chain (C9) of arylomycin A 2 points into a shallow pocket that possibly could be the S5 binding pocket. The overall path traced out by the inhibitor suggests that pre-proteins may interact more with the residues that make up the N-terminal ␤-strand (83-90) than the residues that make up the strand containing the general base (142-145). It is presumed from the primary sequence analysis of signal peptides and the thickness of the lipid bilayer that residues after the P6 residue, namely P7 and the other residues forming the hydrophobic core of the signal peptide would form a helical structure and not be available for main chain interactions with SPase. Future crystal structures of mutant enzyme with peptide substrates will help to clarify and confirm the enzyme-substrate contacts.
